Show simple item record

dc.contributor.advisorSilvia Corvera, MD
dc.contributor.authorRojas-Rodriguez, Raziel
dc.date2022-08-11T08:08:38.000
dc.date.accessioned2022-08-23T16:02:09Z
dc.date.available2022-08-23T16:02:09Z
dc.date.issued2019-07-17
dc.date.submitted2019-09-09
dc.identifier.doi10.13028/8sqa-6q31
dc.identifier.urihttp://hdl.handle.net/20.500.14038/31269
dc.description.abstractPregnancy induces maternal metabolic adaptations including mild glucose intolerance and weight gain in order to support fetal development and lactation. Adipose tissue (AT) function in gestation is featured by reduced insulin sensitivity and fat mass accrual which partly accounts for the weight gain in pregnant women and adaptation of glucose metabolism. A common metabolic pregnancy complication is gestational diabetes mellitus (GDM), a disease characterized by impaired glucose tolerance with onset in gestation. However, the relationship between AT expandability and glucose metabolism in gestation is not well understood. The goal of this thesis was to investigate the adaptations of human AT expansion induced by pregnancy, how these changes are reflected in pregnancies complicated with GDM and characterize a mouse model to study the mechanisms underlying this disease. This dissertation illustrates that pregnancy promotes AT expandability by a signaling mechanism between placental pregnancy-associated plasma protein-A (PAPP-A) and AT- insulin-like growth factor binding protein-5 (IGFBP5). In addition, gravidas with GDM showed impaired AT expansion. Studies investigating the relationship between PAPP-A and glycemic state demonstrated that low levels of PAPP-A in the 1sttrimester are highly associated with the development of GDM. Moreover, PAPP-A knockout mice exhibit reduced insulin sensitivity and impaired AT growth exclusively in gestation. These results expand the knowledge of AT biology in gestation and have the potential to improve maternal care by proposing PAPP-A as an early biomarker and possible therapeutic for GDM. It also introduces a new mouse model to study the etiology of gestational diabetes.
dc.language.isoen_US
dc.publisherUniversity of Massachusetts Medical Schoolen_US
dc.rightsLicensed under a Creative Commons license
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectGestational diabetes
dc.subjectadipose tissue
dc.subjectIGFBP5
dc.subjectPAPP-A
dc.subjectCellular and Molecular Physiology
dc.subjectEndocrinology
dc.subjectEndocrinology, Diabetes, and Metabolism
dc.subjectFemale Urogenital Diseases and Pregnancy Complications
dc.subjectMaternal and Child Health
dc.subjectReproductive and Urinary Physiology
dc.titleAdaptations of Adipose Tissue Expandability in Gestation are Associated with Maternal Glucose Metabolism
dc.typeDoctoral Dissertation
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2057&context=gsbs_diss&unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_diss/1048
dc.legacy.embargo2020-09-09T00:00:00-07:00
dc.identifier.contextkey15292861
refterms.dateFOA2022-08-26T04:27:25Z
html.description.abstract<p>Pregnancy induces maternal metabolic adaptations including mild glucose intolerance and weight gain in order to support fetal development and lactation. Adipose tissue (AT) function in gestation is featured by reduced insulin sensitivity and fat mass accrual which partly accounts for the weight gain in pregnant women and adaptation of glucose metabolism. A common metabolic pregnancy complication is gestational diabetes mellitus (GDM), a disease characterized by impaired glucose tolerance with onset in gestation. However, the relationship between AT expandability and glucose metabolism in gestation is not well understood. The goal of this thesis was to investigate the adaptations of human AT expansion induced by pregnancy, how these changes are reflected in pregnancies complicated with GDM and characterize a mouse model to study the mechanisms underlying this disease. This dissertation illustrates that pregnancy promotes AT expandability by a signaling mechanism between placental pregnancy-associated plasma protein-A (PAPP-A) and AT- insulin-like growth factor binding protein-5 (IGFBP5). In addition, gravidas with GDM showed impaired AT expansion. Studies investigating the relationship between PAPP-A and glycemic state demonstrated that low levels of PAPP-A in the 1<sup>st</sup>trimester are highly associated with the development of GDM. Moreover, PAPP-A knockout mice exhibit reduced insulin sensitivity and impaired AT growth exclusively in gestation. These results expand the knowledge of AT biology in gestation and have the potential to improve maternal care by proposing PAPP-A as an early biomarker and possible therapeutic for GDM. It also introduces a new mouse model to study the etiology of gestational diabetes.</p>
dc.identifier.submissionpathgsbs_diss/1048
dc.contributor.departmentProgram in Molecular Medicine
dc.description.thesisprogramTranslational Science
dc.identifier.orcid0000-0003-0341-3903


Files in this item

Thumbnail
Name:
Rojas_Rodriguez_Raziel_reduced ...
Size:
3.717Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Licensed under a Creative Commons license
Except where otherwise noted, this item's license is described as Licensed under a Creative Commons license